Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

514 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The evolving genomic landscape in urothelial cancer.
Kujtan L, Hussain A, Subramanian J, Masood A. Kujtan L, et al. Among authors: masood a. Curr Opin Oncol. 2018 May;30(3):197-202. doi: 10.1097/CCO.0000000000000447. Curr Opin Oncol. 2018. PMID: 29538042 Review.
Comparative proteogenomic analysis of right-sided colon cancer, left-sided colon cancer and rectal cancer reveals distinct mutational profiles.
Imperial R, Ahmed Z, Toor OM, Erdoğan C, Khaliq A, Case P, Case J, Kennedy K, Cummings LS, Melton N, Raza S, Diri B, Mohammad R, El-Rayes B, Pluard T, Hussain A, Subramanian J, Masood A. Imperial R, et al. Among authors: masood a. Mol Cancer. 2018 Dec 21;17(1):177. doi: 10.1186/s12943-018-0923-9. Mol Cancer. 2018. PMID: 30577807 Free PMC article.
Matched Whole-Genome Sequencing (WGS) and Whole-Exome Sequencing (WES) of Tumor Tissue with Circulating Tumor DNA (ctDNA) Analysis: Complementary Modalities in Clinical Practice.
Imperial R, Nazer M, Ahmed Z, Kam AE, Pluard TJ, Bahaj W, Levy M, Kuzel TM, Hayden DM, Pappas SG, Subramanian J, Masood A. Imperial R, et al. Among authors: masood a. Cancers (Basel). 2019 Sep 19;11(9):1399. doi: 10.3390/cancers11091399. Cancers (Basel). 2019. PMID: 31546879 Free PMC article.
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer harboring uncommon EGFR mutations: Focus on afatinib.
Masood A, Kancha RK, Subramanian J. Masood A, et al. Semin Oncol. 2019 Jun;46(3):271-283. doi: 10.1053/j.seminoncol.2019.08.004. Epub 2019 Sep 11. Semin Oncol. 2019. PMID: 31558282 Free article. Review.
Recent preclinical data indicate that second-generation ErbB family blockers, such as afatinib, have a broad activity profile across uncommon EGFR mutations. Emerging evidence indicates that the preclinical data for afatinib are reflected in the clinic. ...To see an abstra …
Recent preclinical data indicate that second-generation ErbB family blockers, such as afatinib, have a broad activity profile across …
514 results